Introduction
Alpha-melanocyte-stimulating hormone (aMSH)' is a 13-amino acid peptide named originally for its ability to stimulate skin pigmentation in amphibians (1) . It is generated by posttranslational enzymatic cleavage ofthe 241 -amino acid precur-primarily identified in the pituitary gland, but the production of POMC-derived peptides is not confined to this organ, because several recent studies have demonstrated POMG peptides in various other tissues (3) (4) (5) (6) . In addition, it was possible to isolate aMSH in considerable quantities from the skin of various species, including humans (7) . Although the origin of aMSH found within the skin has not been determined, it is unlikely to be pituitary derived, because the cutaneous MSH content showed little change after hypophysectomy in rats ( 1 ) .
The melanocyte within the epidermis appears to be one of the primary targets for the melanotropic hormone aMSH (8) . However, several POMC-derived peptides, including aMSH and ACTH, additionally have been recognized as being immunomodulatory mediators (3, 9) . Keratinocytes, the major constituents of the epidermis, are well known to produce a variety of immunoregulatory cytokines ( 10) . Therefore, in the present study, human keratinocytes were investigated for their ability to produce POMC-derived peptides such as aMSH or ACTH.
Methods
Cell culture. The human epidermoid carcinoma cell line A431 (CRL 1555; American Type Culture Collection, Rockville, MD) was maintained in monolayer cultures at 370C in a humidified atmosphere containing 5% CO2. Long-term culture ofnormal human foreskin keratinocytes (HNK) were obtained as previously described and maintained in MCDB153 media (11) .
To investigate the kinetics offactor production, HNK or A431 cells were plated at a density of 1 X 106/ml in petri dishes and supernatants were harvested at different time points (24, 48 , and 72 h), centrifuged at 1,000 g, and stored at -70°C. Supernatants derived from HNK were enriched 10 times using a Cl 8-plus column (Millipore Corp., Bedford, MA). To stimulate POMC-derived peptide production, cells were treated with phorbol myristate acetate (PMA; Sigma Chemical Co., St. Louis, MO) or different cytokines: recombinant human (rh) IL-2 and rhIL-6 (Collaborative Research, Bedford, MA), rhIL-lj and rhGM-CSF (Boehringer Mannheim, Germany), rhIFNy (Ernst Boehringer Institute, Vienna, Austria), rhTNFa (Endogen Inc., Boston, MA) and rh transforming growth factor # (British Biotechnology, Oxford, UK).
In some experiments, cells were exposed to ultraviolet light (UVB FS20 bulbs; Westinghouse Electric Corp., Pittsburgh, PA), with doses ranging from 40 to 120 J/m2 (12) . During UV irradiation, culture medium was replaced by PBS (12) . sequently medium containing 0.2 ACi [3',5'-3H]-L-tyrosine and serial dilutions of epidermal cell-derived supernatants to be tested were added. After 48 h of incubation, medium was removed, treated with activated charcoal, centrifuged, and finally free 3H generated during the conversion from tyrosine to dopa was counted in a liquid scintillation counter (LKB, Bromma, Sweden).
For the detection of ACTH, an RIA (Allegro-HS-ACTH; Nichols Institute, San Juan, CA) was used. This test is sensitive to 15 pg/ml and does not cross-react with other POMC-derived peptides such as aMSH, /3MSH, and fl-endorphin. The statistical significance was calculated by using the Student's t test.
HPLC. Supernatants derived from A43 1 cells were enriched as described above and subjected to a size-exclusion column (bio sil TSK 125, 300 X 7.5 mm; Bio-Rad Laboratories, Inc., Richmond, CA). Elution was carried out with PBS (pH 7.2) at a flow rate of 1.0 ml/min. Column fractions were filter sterilized and stored frozen at -70'C before being tested ( 11) .
Immuneprecipitation of metabolically labeled aMSH. A431 cells (2 x 107) were incubated with or without PMA (10 ng/ml) in serumfree Eagle's MEM (Gibco, BRL, Paisley, Scotland). After 18 h ofincubation, the supernatant was replaced by medium containing "4C-labeled amino acid mixture (12.5 qCi/ml; Amersham Buchler, Braunschweig, Germany) and incubation was continued for a further 48 h. Subsequently, supernatant aMSH was immunoprecipitated with the same aMSH antibody that was used for the RIA (Milab Corp.) ( 15 ) . Proteins were solubilized under denaturing conditions and subsequently subjected to electrophoresis ( 15% SDS-PAGE) ( 16 ) . The proteins thus separated were visualized by autoradiography (Kodak XOmatic AR; -70°C for 2 wk).
Northern blot analysis. For the detection of POMC, a 0.9-kb Hind III cDNA probe kindly provided by J. Clements (South Melbourne, Victoria, Australia) was used. Northern blot analysis was performed as previously described ( 11 ) . Cultured HNK (3 X I0 7 cells) or A431 (1 x I0' cells) were detached by treatment with ice-cold PBS. Total cellular RNA was isolated by 4 M guanidium isothiocyanate/caesium chloride ultracentrifugation and quantitated by reading at 260 nm. 30 Ag of RNA was electrophoresed on 1% agarose/2.2 M formaldehyde gels followed by transfer to nitrocellulose (Schleicher & Schuell, Keene, NH) and prehybridized overnight. The cDNA POMC probe was 3p_ radiolabeled by the random priming method, hybridized over night, and washed under stringent washing conditions ( 17 ) . Equivalent loading and uniformity were assured by ethidium bromide staining of the gels before and after Northern transfer. In addition, equivalent amounts of RNA were verified by hybridizing the blot with a 32P-labeled cDNA probe ( 1.0 kb) for cyclophylin ( lB15), generously provided by J. Douglass (Oregon Health Sciences University, Portland, OR). Autoradiography was carried out at -70°C using Kodak Maximum increase was obtained with 10 U/ml IL-13 after 3 d of culture (Table I) . In contrast, all the other cytokines tested did not alter aMSH production by A431 cells (data not shown).
Because aMSH induces pigmentation in many mammalians, the effect of UVB light on the release of aMSH by A431 cells was tested. Cells were irradiated with UVB light (120 J/ m 2) and supernatants were harvested after 24, 48, or 72 h.
Supernatants obtained 48 or 72 h after UVB exposure contained significantly elevated levels of aMSH (Table I) . If cells were irradiated with < 120 J/m2, aMSH production by A431 cells was not observed (data not shown). Doses of UV exceeding 120 J/m2 were not used in these experiments because this can result in significant cell damage (19) .
To further characterize epidermal cell-derived aMSH, the capacity of an aMSH antibody to precipitate biosynthetically labeled aMSH was investigated. A431 cells were cultured with or without 10 ng/ml PMA and incubated with a '4C-labeled amino acid mixture. Subsequently, supernatants were collected, the presence of aMSH released was analyzed by immunoprecipitation with anti-aMSH, and the precipitates thus obtained were separated by SDS-PAGE carried out under reducing conditions. The antibody precipitated one major protein migrating with a relative molecular mass of 1 kD, which corresponds to the molecular weight of aMSH. Moreover, the specific band detected in PMA-treated supernatants was significantly enhanced compared with that found in untreated cells (Fig. 1) .
To investigate whether epidermal cell-derived aMSH is biologically active, A431 supernatants obtained after 72 h were subjected to HPLC gel filtration before analysis in a tyrosinase bioassay. Tyrosinase-inducing activity eluted in fractions ofthe low molecular weight range, which corresponds to the molecular weight of aMSH (Fig. 2) .
Because ACTH is another major cleavage product of POMC, the ability of A431 cells to produce ACTH was evaluated using an ACTH-specific immunoradiometric assay. Significant amounts of ACTH were detected in A43 1-conditioned medium. The kinetics and inducibility of ACTH in these cells was similar to those observed with epidermal cell-derived aMSH. Like aMSH, the maximum ACTH production by A431 cells was detected 72 h after stimulation with PMA (Table I).
To determine whether POMC-specific mRNA is expressed in human epidermal cells, Northern blot analysis was performed using a human POMC cDNA probe. In A431 cells small amounts of POMC mRNA were found to be expressed constitutively and were upregulated significantly at 4 h after treatment with 10 ng/ml PMA and 10 U/ml IL-I1, (Fig. 3) . Specific transcripts with a size of 1.3 kb were also detected in RNA extracted from HNK after stimulation with 10 U/ml IL-i/ for 4 h, while constitutive expression was under detection limit (Fig. 4) .
Discussion
The present study for the first time provides evidence that normal human keratinocytes and a keratinocyte cell line produce POMC-derived peptides such as aMSH and ACTH. Release of aMSH by keratinocytes was primarily detected by immunoassays yet the use ofa tyrosinase bioassay indicated keratinocytederived aMSH also to be biologically active. Low levels of aMSH and ACTH are constitutively generated by keratinocytes, which are significantly increased by various stimuli. Recently, POMC mRNA transcripts in normal human nonpituitary tissues were found to be truncated molecules lacking the 5' end of the coding region of the mRNA, explaining the low peptide content in comparison to the amount of POMC mRNA expressed (2) . Northern blot analysis has shown that HNK and A43 1 cells express POMC mRNA with a size of 1.3 kb, which is similar to the full-size transcript reported in pituitary tissue.
The fact that aMSH is produced by keratinocytes may have particular biological relevance, because aMSH can stimulate cutaneous pigment cells from various species, including rodents, via cAMP-dependent mechanisms (20) . In humans, whether aMSH regulates pigmentary responses is still a controversial issue (21 ) . However, generalized skin hyperpigmentation has been reported upon aMSH hypersecretion by the pituitary (22) , and humans injected with aMSH or a synthetic analogue of aMSH showed increased skin darkening (23, 24) . Because the present study demonstrates that the production of aMSH by human keratinocytes is induced significantly by UVB radiation, a role of keratinocyte-derived aMSH in UVinduced pigmentation is suggestive.
In addition, POMC peptides have been demonstrated to modulate immune and inflammatory reactions (3). Accordingly, aMSH blocks particular functions ofIL-1, i.e., induction of thymocyte proliferation and PGE2 release by fibroblasts (25) . The ability of either IL-I or TNFa to cause fever, leukocytosis, and enhancement of plasma acute phase proteins also was found to be inhibited by the simultaneous administration ofaMSH (26) . Moreover, aMSH reversed the depressive influences of IL-I or TNFa on the effector phase of contact hypersensitivity in animals (26) . There is even more evidence for the immunomodulatory ability of POMC-derived peptides, because it was shown that aMSH inhibits the production of IFN'y by PBMC (27) . In contrast, the synthesis of IL-IO was found to be upregulated by aMSH (28), and both aMSH as well as ACTH seem to be able to modulate IL-4-and anti-CD40-driven release of IgE by PBMC. ACTH at physiological concentrations increased IgE synthesis, whereas higher doses of ACTH strongly inhibited IgE synthesis by PBMC (27) . Therefore, POMC peptides may play a role in the pathogenesis of allergic diseases and may represent the postulated neuroendocrine arm in diseases such as atopic dermatitis. These findings raise new and important aspects concerning cutaneous inflammation. Because aMSH can antagonize particular biological activities of the proinflammatory cytokine IL-1, it may play a crucial role in the downregulation ofinflammatory reactions in the skin (26) . To obtain more insights into these mechanisms, the signals influencing the release of aMSH by keratinocytes need to be studied. In particular the influence of UV irradiation on the release of aMSH by keratinocytes appears of relevance, because keratinocytes are the main target of UV light, which is known to cause local as well as systemic immunosuppression. Recently, it was found that epicutaneous application of aMSH suppresses both the sensitization and elicitation limbs of the cutaneous immune response to potent contact sensitizers (29) . UV light is well known to suppress the induction of contact hypersensitivity (30) . Thus the UV-induced production of aMSH by keratinocytes may be involved in mediating the suppressive effect on the epicutaneous sensitization response. This is in agreement with previous studies in which mediators released from keratinocytes inhibited contact hypersensitivity when injected intravenously into test animals ( 19) . In summary, the present study demonstrates that human keratinocytes can release POMC-derived peptides, which, in
;
.L-.; .X Equivalent amounts of RNA were verified by hybridizing the blot with a cDNA probe for cyclophylin (IlB15).
